. 2021 Feb 23;11(14):8398–8410. doi: 10.1039/d0ra09606g

In vivo biochemical evaluation of fasting blood glucose (FBG), insulin (INS), homeostasis model assessment of insulin resistance (HOMA-IR) and glucose transporter 4 (Glut 4) among the different groups.

Groups	FBG (mmol L⁻¹)	INS (μIU mL⁻¹)	HOMA-IR	GLUT 4 (ng mL⁻¹)
Normal control	4.79 ± 0.12^a	11.23 ± 0.58^a	2.45 ± 0.14^a	11.66 ± 0.12^a
Diabetic rats	21.41 ± 0.45^b	43.13 ± 4.67^b	41.38 ± 3.67^b	8.61 ± 0.44^b
Plain extract treated group	12.10 ± 1.25^a^,^b	35.03 ± 4.48^b	20.38 ± 3.78^a^,^b	8.42 ± 0.38^b
Standard drug treated group	11.86 ± 0.92^a^,^b	26.30 ± 4.05^a	13.10 ± 2.07^a	9.17 ± 0.66^b
Nano-extract treated group	7.88 ± 0.44^a	13.50 ± 2.14^a	4.82 ± 0.96^a	11.27 ± 0.42^a

P < 0.05 versus diabetic rats.

P < 0.05 versus normal control.